[ET Net News Agency, 12 December 2023] CSTONE PHARMA-B (02616) rose 10.1% to HK$2.61.
It hits an intra-day high of HK$2.61, and an intra-day low of HK$2.33. The total shares
traded was 10.11 million, with a value of HK$25.56m. The active buy/sell ratio is 70:30,
with net buying turnover of HK$10.23m. J.P. MORGAN BRO (HK) accounts for greatest net
responsive buying turnover of HK$73,278, with volume weighted average price of HK$2.508.
CHINA INV INFO accounts for greatest net responsive selling turnover of HK$2.03m, with
volume weighted average price of HK$2.534.
Basic Information
=================
----------------------------------
Nominal 2.610 % Chg +10.13%
High 2.610 Low 2.330
Shares Tr 10.11m Turnover 25.56m
10-D SMA 2.243 %H.V 79.805
20-D SMA 2.325 VWAP 2.528
50-D SMA 2.128 RSI14 64.481
----------------------------------
Status: Active buy/sell ratio is 70:30, with net buying turnover of HK$10.23m
Performance of stocks in the same sector or of relevance
========================================================
Stock (Code) Price (HK$) Change (%)
-----------------------------------------------
CSTONE PHARMA-B (02616) 2.61 +10.13
HUTCHMED (00013) 29.80 +1.71
GENSCRIPT BIO (01548) 19.92 -0.10
INNOVENT BIO (01801) 39.45 -2.23
JXR (01951) 3.30 -3.51
KEYMED BIO-B (02162) 52.10 +2.06
WUXI BIO (02269) 28.45 -0.52
BEIGENE (06160) 105.80 -0.28
ZAI LAB (09688) 20.30 -0.25
AKESO (09926) 45.55 +4.11
-----------------------------------------------
(ed)